| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/02/2010 | EP2190993A2 Compositions comprising stat5 sirna and methods of use thereof |
| 06/02/2010 | EP2190990A1 Pthrp, its isoforms and antagonist thereto in the diagnosis and treatment of disease |
| 06/02/2010 | EP2190985A1 Cancer-related genes, cdca5, epha7, stk31 and wdhd1 |
| 06/02/2010 | EP2190880A1 Cytotoxicity mediation of cells evidencing surface expression of cd9 |
| 06/02/2010 | EP2190879A1 Novel antibodies |
| 06/02/2010 | EP2190870A1 Cell marker of melanocyte cell lineage and uses thereof |
| 06/02/2010 | EP2190849A2 Compounds useful as protein kinases inhibitors |
| 06/02/2010 | EP2190845A2 Hdac inhibitors |
| 06/02/2010 | EP2190843A1 Benzimidazole nf- kappab inhibitors |
| 06/02/2010 | EP2190836A1 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
| 06/02/2010 | EP2190834A1 Pyridoneamide derivatives as focal adhesion kinase (fak) inhibitors and their use for the treatment of cancer |
| 06/02/2010 | EP2190826A2 2-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitors |
| 06/02/2010 | EP2190483A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 06/02/2010 | EP2190482A2 Targeted block copolymer micelles |
| 06/02/2010 | EP2190478A1 Dkk1 oncogene as therapeutic target for cancer and a diagnosing marker |
| 06/02/2010 | EP2190464A2 Use of leptin(22-56) as a therapeutic agent |
| 06/02/2010 | EP2190463A2 Use of thymopentin as a therapeutic agent |
| 06/02/2010 | EP2190459A1 Use of cnp-22, alone1 or in combination with physalemin, as a therapeutic agent |
| 06/02/2010 | EP2190456A2 Use of beta-melanotropin as a therapeutic agent, eg for the treatment of aids or alzheimer |
| 06/02/2010 | EP2190453A2 Use of trp6-triptorelin and d-leu6-leuprolide as therapeutic agents |
| 06/02/2010 | EP2190452A2 Use of a peptide as a therapeutic agent |
| 06/02/2010 | EP2190450A2 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 06/02/2010 | EP2190448A2 Methods and uses thereof of prosaposin |
| 06/02/2010 | EP2190447A2 Use of stresscopin-related peptide as a therapeutic agent |
| 06/02/2010 | EP2190434A2 Purin derivatives for use in the treatment of fab-related diseases |
| 06/02/2010 | EP2190429A1 A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors |
| 06/02/2010 | EP2190426A1 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
| 06/02/2010 | EP2190292A1 ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF |
| 06/02/2010 | EP2190287A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 06/02/2010 | EP1817057B1 Sodium stibogluconate and il-2 for treating cancer |
| 06/02/2010 | EP1712642B1 Method of examining sensitivity of cancer cell to anticancer agent |
| 06/02/2010 | EP1658263B1 Novel aminobenzophenone compounds |
| 06/02/2010 | EP1608650B1 Pyrene-linked pyrrolo(2,1-c)(1,4)benzodiazepine derivatives useful as anticancer agents |
| 06/02/2010 | EP1438299B1 Bifunctional chelating agent for actinium |
| 06/02/2010 | EP1425016B1 Compositions and methods of treatment of cancer |
| 06/02/2010 | EP1352970B1 Method of estimating the risk of expression of adverse drug reaction caused by the administration of a compound, which is either metabloized per se by ugt1a1 or whose intermediate is metabolized by the enzyme |
| 06/02/2010 | EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance |
| 06/02/2010 | EP1066050B2 Application of hsp70 proteins |
| 06/02/2010 | DE69224660C5 Mitteln zur modulierung von verfahren durch retinoid rezeptoren und dafür nützliche verbindungen Means for modulating process by retinoid receptors and for useful links |
| 06/02/2010 | DE112008001179T5 Mittel für die Behandlung und zur Vorsorge von gutartiger Prostatahyperplasie, Prostatitis, Impotenz, Unfruchtbarkeit und Prostatakarzinom und das Verfahren seiner Anwendung Agents for the treatment and prevention of benign prostatic hyperplasia, prostatitis, impotence, infertility, and prostate cancer, and the method of its application |
| 06/02/2010 | CN1972698B Beta-hydroxy short to medium chain fatty acid polymer |
| 06/02/2010 | CN1957927B Fat micro sphere preparation of triterpenoid saponin and derivative, and fabricating method |
| 06/02/2010 | CN1895337B Pharmaceutical use of Tangshen and Milkvetch root composition for improving life quality of late tumor patient |
| 06/02/2010 | CN1886353B Methods of [11C]-radiolabelling phenothiazine and phenothiazine-like compounds |
| 06/02/2010 | CN1872828B Monocyclic polysubstitution cyclohexenol, and compound of ketones, and preparation method, and usage |
| 06/02/2010 | CN1840530B Process for preparing pemetrexed |
| 06/02/2010 | CN1835951B Isethionate salt of a selective CDK4 inhibitor |
| 06/02/2010 | CN1826336B Cyclohexanecarboxylic acid compound |
| 06/02/2010 | CN1659180B Novel recombinant anticoagulant proteins |
| 06/02/2010 | CN1354755B Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/02/2010 | CN1291231B Human telomerase catalytic subunit |
| 06/02/2010 | CN101720436A Methods and agents for inhibiting tumor growth by targeting the ssdna replication intermediate of tumor stem cells |
| 06/02/2010 | CN101720323A Compounds with anti-cancer activity |
| 06/02/2010 | CN101720322A Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 06/02/2010 | CN101720318A Quinazolin-oxime derivatives as hsp90 inhibitors |
| 06/02/2010 | CN101720315A Novel derivatives of psammaplin a, a method for their synthesis and their use for the prevention or treatment of cancer |
| 06/02/2010 | CN101720222A Drug having effect of promoting hepatocyte growth |
| 06/02/2010 | CN101717775A Single-chain antibody gene of anti-human death receptor 5 |
| 06/02/2010 | CN101717449A Recombinant TRAIL-Fc fusion protein as well as preparation and application thereof |
| 06/02/2010 | CN101717433A Polypeptide immunogen, preparation method and application thereof |
| 06/02/2010 | CN101717413A Chiral ruthenium coordination compound and application of same as anti-tumour medicine |
| 06/02/2010 | CN101717411A Methyl-removal cantharidin derivative phosphate disodium salt and synthesis method and application thereof |
| 06/02/2010 | CN101717410A Phosphorus-containing compounds & uses thereof |
| 06/02/2010 | CN101717402A Pyrazolo N-substituted dehydronorcantharidin imide derivative and synthesis method and application thereof |
| 06/02/2010 | CN101717397A Substituted pyridino-[2',1':2,3] imidazo[4,5-c] isoquinolone compounds, method for synthesizing same, use of same and medicinal composition having same |
| 06/02/2010 | CN101717385A Terpenoids, and preparation method and applications thereof. |
| 06/02/2010 | CN101717373A Diaryl urea derivative and application thereof |
| 06/02/2010 | CN101716352A Antisense oligonucleotide nano preparation resisting middle-period factor, preparation and application thereof |
| 06/02/2010 | CN101716351A Use of pyridine compound in preparation of RNA interference reinforcing agent |
| 06/02/2010 | CN101716349A Medicine composite used for embolotherapy and acesodyne and preparation method thereof |
| 06/02/2010 | CN101716348A Construction and application of gold-magnetic nanoparticle-based medicament carrying platform |
| 06/02/2010 | CN101716346A Supramolecular hydrogel gene vector material, and preparation method and application thereof |
| 06/02/2010 | CN101716343A Freeze-drying preparation of monoclonal antibody |
| 06/02/2010 | CN101716339A IL-12 and TNF-alpha autologous tumor vaccine |
| 06/02/2010 | CN101716335A Stable recombinant human interferon ointment |
| 06/02/2010 | CN101716318A Traditional Chinese medicine preparation for treating tumor of digestive system |
| 06/02/2010 | CN101716316A Traditional Chinese medicine decoction for treating breast cancer |
| 06/02/2010 | CN101716314A Orally taken traditional Chinese medicine composite for treating bladder cancer |
| 06/02/2010 | CN101716283A Method for constructing dendrobium officinale polysaccharide fingerprinting |
| 06/02/2010 | CN101716280A Medicine composite used for curing liver cancer |
| 06/02/2010 | CN101716278A Medicament for preventing and treating cancers and preparation method thereof |
| 06/02/2010 | CN101716256A Preparation used for strengthening immunity and inhibiting tumor |
| 06/02/2010 | CN101716225A Medicament for treating liver cancer and preparation method thereof |
| 06/02/2010 | CN101716215A Quality detection method of traditional Chinese medicine of isatis root |
| 06/02/2010 | CN101716209A Artemisia dalai-lamae Krasch. essential oil and preparation method and application thereof |
| 06/02/2010 | CN101716206A Wild ginseng granules and preparation method thereof |
| 06/02/2010 | CN101716204A Anticancer analgesic preparation and preparation method thereof |
| 06/02/2010 | CN101716199A Method for extracting flavonoids from leaves of cotton rose hibiscus |
| 06/02/2010 | CN101716192A Method for separating pharmacodynamic substances of Chinese medicinal mole crickets by utilizing high-speed countercurrent chromatography |
| 06/02/2010 | CN101716178A Antitumor medicament |
| 06/02/2010 | CN101716175A New application of 3-amido-6-(4-methoxyphenyl) thiopheno[2, 3-b] pyridine-2-formamide |
| 06/02/2010 | CN101716172A Application of miltipolone or pharmaceutically acceptable salts thereof in pharmacy |
| 06/02/2010 | CN101716169A Docetaxel medicinal composition and preparation method thereof |
| 06/02/2010 | CN101716167A Use of saturated amine compound in preparation of medicaments for mobilizing peripheral blood hematopoietic stem cells |
| 06/02/2010 | CN101716163A Letrozole targeted slow-release transdermal patch and preparation method thereof |
| 06/02/2010 | CN101716161A New thymosin chitosan microsphere type oral medicinal preparation and preparation method thereof |
| 06/02/2010 | CN101716158A Method for preparing matrine slow-release tablet by applying attapulgite |
| 06/02/2010 | CN101716156A Ubenimex dispersive tablet composition |
| 06/02/2010 | CN101716154A Ursolic acid oral dispersant and preparation method thereof |
| 06/02/2010 | CN101716145A Modified chitosan targeted medicament carrying nano microsphere and preparation method thereof |